A detailed history of Vident Advisory, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Vident Advisory, LLC holds 38,513 shares of ZTS stock, worth $6.74 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
38,513
Previous 40,270 4.36%
Holding current value
$6.74 Million
Previous $7.95 Billion 18.01%
% of portfolio
0.14%
Previous 0.2%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$165.67 - $199.94 $291,082 - $351,294
-1,757 Reduced 4.36%
38,513 $6.52 Billion
Q4 2023

Feb 14, 2024

BUY
$151.44 - $200.09 $776,584 - $1.03 Million
5,128 Added 14.59%
40,270 $7.95 Billion
Q3 2023

Feb 21, 2024

SELL
$167.14 - $192.77 $857,093 - $988,524
-5,128 Reduced 12.73%
35,142 $6.11 Billion
Q3 2023

Nov 14, 2023

BUY
$167.14 - $192.77 $5.87 Million - $6.77 Million
35,142 New
35,142 $6.11 Billion

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $81.9B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Vident Advisory, LLC Portfolio

Follow Vident Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Advisory, LLC with notifications on news.